Alkaloid marks its 23rd participation in CPHI (Convention on Pharmaceutical Ingredients), a leading global event connecting stakeholders across the entire pharmaceutical supply chain. The 37th edition of CPHI is taking place from October 6 to October 8 in Milan, Italy, bringing the pharmaceutical community together for networking, knowledge exchange, the showcasing of innovations, and the creation of new business opportunities.
Alkaloid’s participation in CPHI Milan 2026 coincides with the company’s 90th anniversary, with the exhibition focusing on its modern manufacturing facilities, product portfolio, and key development achievements.
Alkaloid’s team, comprising 35 representatives from various organizational sectors, held numerous meetings over the three-day event with business partners, suppliers, and potential collaborators. The primary focus was on deepening existing partnerships, developing new business opportunities, and expanding international cooperation with leading players in the pharmaceutical industry.
With over 62,000 pharmaceutical professionals and more than 2,900 exhibitors from around the globe, CPHI, one of the world’s most renowned pharmaceutical gatherings, brings together companies, experts, and innovators. It offers a modern platform for showcasing the latest technologies and establishing strategic partnerships that unlock new opportunities for developing the next generation of innovative pharmaceutical solutions.